Navigation Links
Cantox Announces the Launch of Ashuren Health Sciences Pharmaceutical Division
Date:1/10/2008

MISSISSAUGA, Ontario, BRIDGEWATER, New Jersey and BIRMINGHAM, Alabama, Jan. 10 /PRNewswire/ -- CANTOX HEALTH SCIENCES INC. and CANTOX US INC., a leading international scientific and regulatory consulting firm with specialized expertise in the areas of Pharmaceutical & Healthcare, Food & Nutrition, Chemicals and Agriculture, Biotech & Consumer Products announces the launch of Ashuren Health Sciences as the new name for their Pharmaceutical & Healthcare Division.

For the past 20 years, Cantox has been helping clients resolve complex scientific and toxicology issues, develop scientific and strategic regulatory plans, and facilitating timely regulatory global approvals. Cantox has been optimizing success and minimizing client risk through broad expertise and knowledge.

"The decision to rename the Pharmaceutical & Healthcare Division 'ASHUREN Health Sciences' was taken in order to more accurately represent our expanding global client base and to reflect our diverse international regulatory agency interactions," said Lindsay N. Donald, Vice President of Ashuren Pharmaceutical & Healthcare. "We have been assisting clients with their toxicology and drug development issues in Europe, North America, Asia and Australia."

"In order to rapidly and cost effectively move drugs through development it is imperative to anticipate scientific and regulatory issues ahead of time," commented Anna Metcalfe, Vice President of Regulatory Affairs for Ashuren. "This is where the experience of Ashuren's scientific and regulatory affairs consultants can really aid our pharmaceutical and biotech clients."

About Ashuren

Ashuren Health Sciences is a focused team of scientific and regulatory consultants that can help develop strategies, provide expert advice on all aspects of product development programs, and provide advice on a wide variety of toxicology and regulatory issues for pharmaceutical and related products. With diverse and in-depth experience in pharmaceutical development, our resourceful and innovative team consisting of board-certified toxicologists, regulatory affairs specialists and scientific writers address client's needs and accelerate their development programs. For more information, please visit: http://www.ashuren.com.


'/>"/>
SOURCE Ashuren Health Sciences
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... DUBLIN , Jan 13, 2017 Research and ... report to their offering. ... The global biopolymers market to grow at a CAGR of 16.83% ... scenario and the growth prospects of the global biopolymers market for 2017-2021. ... the sale of sales of biopolymer products. The report also includes a ...
(Date:1/13/2017)... ... 13, 2017 , ... FireflySci, in response to several customers’ ... solutions for measurements where traditional cuvette applications are not convenient. For instance, a ... sample that would not fit into a typical cuvette inside a spectrophotometer. In ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... times capable of performing routine electrochemical biosensing has increased dramatically. Primarily driven ... sensitive detection and quantification of various analytes in complex samples. ...
(Date:1/12/2017)... 2017 The Energy and Resources ... for producing mycorrhizae. The Centre for Mycorrhizal Research at ... mycorrhizae and developed a technology that eventually produces mycorrhizae ... ... The TERI facility has a production capacity of ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... Advancements in biometrics will radically ... wellbeing (HWW), and security of vehicles by ... vehicles begin to feature fingerprint recognition, iris ... monitoring, brain wave monitoring, stress detection, fatigue ... detection. These will be driven by built-in, ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
Breaking Biology News(10 mins):